Drugs / membrane-inhibiting formula
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06417736 | Dec 2023 → Jul 2025 overdue | endometrial cancer | Women's Hospital School Of Medicine Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | membrane-inhibiting formula | “membrane-inhibiting formula plus oral progestins as fertility-preserving treatment” NCT06417736 ↗ |